Houlihan Lokey Advises closerlook

Houlihan Lokey is pleased to announce that closerlook has been acquired by Fishawack Health, a portfolio company of Bridgepoint Advisers. The transaction closed on May 27, 2021.

closerlook is a digital-native healthcare agency that leverages artificial intelligence (AI) and data analytics to develop omnichannel strategies, creative, and digital media solutions for life science brands across the entire pre-commercial and commercial lifecycle of a drug.

The award-winning firm’s skills and software products in data science, AI, and advanced analytics provide life science brands with real-time insights, providing the ability to develop hypertargeted and precisely personalized campaigns at scale. This expertise, combined with Fishawack Health’s broad spectrum of medical communications, commercial, and consulting capabilities, will provide healthcare marketers with unrivaled access to an integrated platform, designed for competitive advantage.

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the U.K., the organization is powered by a 1,100+ globe-spanning pack of strategic, creative, and scientific experts. The firm aims to drive change with HCPs and affect patient lives.

Bridgepoint Advisers is a London-based international alternative asset fund management group focusing on the middle market. Bridgepoint’s purpose is to grow the capital of its investors and their pension holders by investing responsibly in well-managed businesses and helping them expand and prosper. The firm currently manages middle-market private equity, early-stage growth, and credit funds with more than $31 billion in assets under management.

Houlihan Lokey served as the financial advisor to closerlook and assisted in structuring and negotiating the transaction on its behalf.